This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lindberg, R. A.
Right arrow Articles by Fletcher, F. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lindberg, R. A.
Right arrow Articles by Fletcher, F. A.

 Previous Article  |  Next Article 

Mol Cell Biol, June 1998, p. 3357-3367, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.

Cloning and Characterization of a Specific Receptor for Mouse Oncostatin M

Richard A. Lindberg,1 Todd S.-C. Juan,2 Andrew A. Welcher,1 Yu Sun,2 Rod Cupples,1 Brenda Guthrie,1 and Frederick A. Fletcher2,*

Departments of Pathology2 and Immunology,1 Amgen, Inc., Thousand Oaks, California 91320-1789

Received 5 December 1997/Returned for modification 9 February 1998/Accepted 2 March 1998

Oncostatin M (OSM) is a member of a family of cytokines that includes ciliary neurotrophic factor, interleukin-6, interleukin-11, cardiotrophin-1, and leukemia inhibitory factor (LIF). The receptors for these cytokines consist of a common signaling subunit, gp130, to which other subunits are added to modify ligand specificity. We report here the isolation and characterization of a cDNA encoding a subunit of the mouse OSM receptor. In NIH 3T3 cells (which endogenously express gp130, LIF receptor beta  [LIFRbeta ], and the protein product, c12, of the cDNA described here), mouse LIF, human LIF, and human OSM signaled through receptors containing the LIFRbeta and gp130 but not through the mouse OSM receptor. Mouse OSM, however, signaled only through a c12-gp130 complex; it did not use the LIF receptor. Binding studies demonstrated that mouse OSM associated directly with either the c12 protein or gp130. These data highlight the species-specific differences in receptor utilization and signal transduction between mouse and human OSM. In mouse cells, only mouse OSM is capable of activating the mouse OSM receptor; human OSM instead activates the LIF receptor. Therefore, these data suggest that all previous studies with human OSM in mouse systems did not elucidate the biology of OSM but, rather, reflected the biological actions of LIF.


* Corresponding author. Mailing address: Amgen, Inc., 1840 Dehavilland Dr., M/S 99-1-A, Thousand Oaks, CA 91320-1789. Phone: (805) 447-8829. Fax: (805) 499-7506. E-mail: fredf{at}amgen.com.


Mol Cell Biol, June 1998, p. 3357-3367, Vol. 18, No. 6
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Juan, T.S.-C., Bolon, B., Lindberg, R. A., Sun, Y., Van, G., Fletcher, F. A. (2009). Mice Overexpressing Murine Oncostatin M (OSM) Exhibit Changes in Hematopoietic and Other Organs that Are Distinct from Those of Mice Overexpressing Human OSM or Bovine OSM. Vet Pathol 46: 124-137 [Abstract] [Full Text]  
  • Tiffen, P. G., Omidvar, N., Marquez-Almuina, N., Croston, D., Watson, C. J., Clarkson, R. W. E. (2008). A Dual Role for Oncostatin M Signaling in the Differentiation and Death of Mammary Epithelial Cells in Vivo. Mol. Endocrinol. 22: 2677-2688 [Abstract] [Full Text]  
  • Hintzen, C., Haan, C., Tuckermann, J. P., Heinrich, P. C., Hermanns, H. M. (2008). Oncostatin M-Induced and Constitutive Activation of the JAK2/STAT5/CIS Pathway Suppresses CCL1, but Not CCL7 and CCL8, Chemokine Expression. J. Immunol. 181: 7341-7349 [Abstract] [Full Text]  
  • Miyaoka, Y., Tanaka, M., Naiki, T., Miyajima, A. (2006). Oncostatin M Inhibits Adipogenesis through the RAS/ERK and STAT5 Signaling Pathways. J. Biol. Chem. 281: 37913-37920 [Abstract] [Full Text]  
  • Fritz, D. K., Kerr, C., Tong, L., Smyth, D., Richards, C. D. (2006). Oncostatin-M Up-Regulates VCAM-1 and Synergizes with IL-4 in Eotaxin Expression: Involvement of STAT6. J. Immunol. 176: 4352-4360 [Abstract] [Full Text]  
  • Terra, R., Louis, I., Le Blanc, R., Ouellet, S., Zuniga-Pflucker, J. C., Perreault, C. (2005). T-cell generation by lymph node resident progenitor cells. Blood 106: 193-200 [Abstract] [Full Text]  
  • Weiss, T. W, Speidl, W. S, Kaun, C., Rega, G., Springer, C., Macfelda, K., Losert, U. M, Grant, S. L, Marro, M. L, Rhodes, A. D, Fuernkranz, A., Bialy, J., Ullrich, R., Holzmann, P., Pacher, R., Maurer, G., Huber, K., Wojta, J. (2003). Glycoprotein 130 ligand oncostatin-M induces expression of vascular endothelial growth factor in human adult cardiac myocytes. Cardiovasc Res 59: 628-638 [Abstract] [Full Text]  
  • Langdon, C., Kerr, C., Tong, L., Richards, C. D. (2003). Oncostatin M Regulates Eotaxin Expression in Fibroblasts and Eosinophilic Inflammation in C57BL/6 Mice. J. Immunol. 170: 548-555 [Abstract] [Full Text]  
  • Matsui, T., Kinoshita, T., Hirano, T., Yokota, T., Miyajima, A. (2002). STAT3 Down-regulates the Expression of Cyclin D during Liver Development. J. Biol. Chem. 277: 36167-36173 [Abstract] [Full Text]  
  • Palmqvist, P., Persson, E., Conaway, H. H., Lerner, U. H. (2002). IL-6, Leukemia Inhibitory Factor, and Oncostatin M Stimulate Bone Resorption and Regulate the Expression of Receptor Activator of NF-{kappa}B Ligand, Osteoprotegerin, and Receptor Activator of NF-{kappa}B in Mouse Calvariae. J. Immunol. 169: 3353-3362 [Abstract] [Full Text]  
  • de Hooge, A. S. K., van de Loo, F. A. J., Bennink, M. B., de Jong, D. S., Arntz, O. J., Lubberts, E., Richards, C. D., van den Berg, W. B. (2002). Adenoviral Transfer of Murine Oncostatin M Elicits Periosteal Bone Apposition in Knee Joints of Mice, Despite Synovial Inflammation and Up-Regulated Expression of Interleukin-6 and Receptor Activator of Nuclear Factor-{kappa}B Ligand. Am. J. Pathol. 160: 1733-1743 [Abstract] [Full Text]  
  • Wahl, A F, Wallace, P M (2001). Oncostatin M in the anti-inflammatory response. Ann Rheum Dis 60: iii75-80 [Abstract] [Full Text]  
  • Kerfoot, S. M., Raharjo, E., Ho, M., Kaur, J., Serirom, S., McCafferty, D.-M., Burns, A. R., Patel, K. D., Kubes, P. (2001). Exclusive Neutrophil Recruitment with Oncostatin M in a Human System. Am. J. Pathol. 159: 1531-1539 [Abstract] [Full Text]  
  • Langdon, C., Kerr, C., Hassen, M., Hara, T., Arsenault, A. L., Richards, C. D. (2000). Murine Oncostatin M Stimulates Mouse Synovial Fibroblasts in Vitro and Induces Inflammation and Destruction in Mouse Joints in Vivo. Am. J. Pathol. 157: 1187-1196 [Abstract] [Full Text]  
  • Auernhammer, C. J., Melmed, S. (2000). Leukemia-Inhibitory Factor--Neuroimmune Modulator of Endocrine Function. Endocr. Rev. 21: 313-345 [Abstract] [Full Text]  
  • Yao, L., Setiadi, H., Xia, L., Laszik, Z., Taylor, F. B., McEver, R. P. (1999). Divergent Inducible Expression of P-Selectin and E-Selectin in Mice and Primates. Blood 94: 3820-3828 [Abstract] [Full Text]  
  • Kinoshita, T., Sekiguchi, T., Xu, M.-j., Ito, Y., Kamiya, A., Tsuji, K.-i., Nakahata, T., Miyajima, A. (1999). Hepatic differentiation induced by oncostatin M attenuates fetal liver hematopoiesis. Proc. Natl. Acad. Sci. USA 96: 7265-7270 [Abstract] [Full Text]  
  • Zhong, J., Dietzel, I. D., Wahle, P., Kopf, M., Heumann, R. (1999). Sensory Impairments and Delayed Regeneration of Sensory Axons in Interleukin-6-Deficient Mice. J. Neurosci. 19: 4305-4313 [Abstract] [Full Text]  
  • Wallace, P. M., MacMaster, J. F., Rouleau, K. A., Brown, T. J., Loy, J. K., Donaldson, K. L., Wahl, A. F. (1999). Regulation of Inflammatory Responses by Oncostatin M. J. Immunol. 162: 5547-5555 [Abstract] [Full Text]  
  • Loy, J. K., Davidson, T. J., Berry, K. K., Macmaster, J. F., Danle, B., Durham, S. K. (1999). Oncostatin M: Development of a Pleiotropic Cytokine. Toxicol Pathol 27: 151-155 [Abstract]  
  • Tanaka, M., Hara, T., Copeland, N. G., Gilbert, D. J., Jenkins, N. A., Miyajima, A. (1999). Reconstitution of the Functional Mouse Oncostatin M (OSM) Receptor: Molecular Cloning of the Mouse OSM Receptor beta  Subunit. Blood 93: 804-815 [Abstract] [Full Text]  
  • Wang, Y., Robledo, O., Kinzie, E., Blanchard, F., Richards, C., Miyajima, A., Baumann, H. (2000). Receptor Subunit-specific Action of Oncostatin M in Hepatic Cells and Its Modulation by Leukemia Inhibitory Factor. J. Biol. Chem. 275: 25273-25285 [Abstract] [Full Text]  
  • Blanchard, F., Duplomb, L., Wang, Y., Robledo, O., Kinzie, E., Pitard, V., Godard, A., Jacques, Y., Baumann, H. (2000). Stimulation of Leukemia Inhibitory Factor Receptor Degradation by Extracellular Signal-regulated Kinase. J. Biol. Chem. 275: 28793-28801 [Abstract] [Full Text]